期刊文献+

OXTR基因在甲状腺癌组织中的甲基化状态 被引量:1

OXTR Gene Methylation in Thyroid Cancer Tissues
原文传递
导出
摘要 [目的]研究甲状腺癌组织与癌旁正常组织OXTR基因甲基化状态并进行比较,初步探讨OXTR基因甲基化修饰与其表达之间的关系。[方法]利用甲基化特异性PCR(MSP)技术扩增甲状腺癌患者癌组织与癌旁组织DNA甲基化(M)和非甲基化(U)OXTR基因各17例,比较两组甲基化程度差异。[结果]MSP实验结果显示,癌组织(病例组17例)中有11例呈现OXTR基因甲基化条带扩增,其余为OXTR非甲基化条带扩增,甲基化率达到64.7%;癌旁组织(对照组17例)有4例呈现OXTR基因甲基化条带扩增,13例样品皆为OXTR非甲基化条带扩增,对照组OXTR甲基化率为23.5%;两组甲基化程度差异有统计学意义(P<0.05)。[结论]OXTR基因DNA甲基化修饰程度癌组织高于癌旁组织,结合前期血液OXTR基因甲基化修饰研究,该基因甲基化可能是早期肿瘤标志,其检测结果可作为辅助诊断甲状腺癌的有效方法。 [Objective] To study and compare the thyroid cancer tissues with normal tissues adjacent to carcinoma on OXTR gene methylation status, and assess the relationship of OXTR gene methylation modification with its expression. [Methods] Methylation-specific PCR(MSP) technology was applied to amplify methylated(M) and unmethylated(U) OXTR gene from 17 thyroid cancer tissue samples and 17 surrounding tissue samples and compare differences in methylation levels between the two groups. [Results] The MSP results showed that 11 out of the 17 cancer tissue samples presented methylated OXTR gene(methylation rate, 64.7%) and other samples presented unmethylated OXTR gene; whereas 4 and 13 out of the 17 adjacent tissue samples did so(methylation rate, 23.5%); there had a significant difference between the two groups in the degree of methylation(P〈0.05). [Conclusion] A higher degree of OXTR gene DNA methylation modification is identified in cancer tissues than in the tissues adjacent to carcinoma. Combined with previous studies on blood OXTR gene methylation modification, the gene methylation as an early tumor marker could be used in auxiliary diagnosis of thyroid carcinoma.
出处 《环境与职业医学》 CAS CSCD 北大核心 2016年第4期390-393,共4页 Journal of Environmental and Occupational Medicine
基金 上海市卫生局科研课题资助项目(编号:20124375)
关键词 表观遗传学 甲状腺癌 DNA甲基化 生物标志 epigenetics thyroid cancer DNA methylation biomarker
  • 相关文献

参考文献16

  • 1Hegedus L. Clinical practice : the thyroid nodule[ J ]. N Engl J Med, 2004, 351( 17 ): 1764-1771.
  • 2Enewold L, Zhu K, Ron E, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005[ J ]. Cancer Epidemiol Biomarkers Prey, 2009, 18( 3 ): 784-791.
  • 3Grodski S, Delbridge L. An update on papillary microcarcinoma [J].CurrOpinOncol, 2009, 21(1): 1-4.
  • 4廖萍,刘茶珍,罗全勇,王金普,朱佩云,翁康生,顾国浩,蒋敏,吴凡,王文静.甲状腺癌患者血DNA甲基化分子标志物[J].环境与职业医学,2012,29(2):77-82. 被引量:5
  • 5Zhong S, Fields C R, Su N, et al. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer [ J ]. Oncogene, 2007, 26( 18 ): 2621-2634.
  • 6Taylor S E. Tend and befriend: Biobehavioral bases of affiliation under stress [ J ]. Curr Dir Psychol Sci, 2006, 15: 273-277.
  • 7Gregory S G, Connelly J J, Towers A J, et al. Genomic and epigenetic evidence for oxytocin receptor deficiency [ J ]. BMC Med, 2009, 7: 62.
  • 8Mizumoto Y, Kimura T, Ivell R. A genomic element within the third intron of the human oxytocin receptor gene may be involved in transcriptional suppression [ J ]. Mol Cell Endocrinol, 1997, 135(2): 129-138.
  • 9Jones P A, Baylin S B. The fundamental role of epigenetic events in cancer[ J ]. Nat Rev Genet, 2002, 3( 6 ): 415-428.
  • 10Partha M, Rakesh S. DNA methylation and cancer[ J ]. J Clin Ontology, 2004, 2( 22 ): 4632-4642.

二级参考文献24

  • 1关海霞,单忠艳,米小轶,王恩华,滕卫平.普遍食盐碘化前后甲状腺癌发病变化的11年病理资料分析[J].中国医科大学学报,2006,35(3):284-285. 被引量:106
  • 2HEGEDOS L. Chnical practice. The thyroid nodule[ J ]. N Engl J Med, 2004, 351( 17 ): 1764-1771.
  • 3HUNDAHL S A, FLEMING I D, FREMGEN A M, et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 ( see commetns )[ J ]. Cancer, 1998, 83( 12 ): 2638-2648.
  • 4PARTHA MD, RAKESH S. DNA methylation and cancer[ J ]. J Clin Oncology, 2004, 2( 22 ): 4632-4642.
  • 5MULLER H M, WIDSCHWENDTER M. Methylated DNA as a possible screening marker for neoplastic disease in several body fluids [ J ]. Expert Rev Mol Diagn, 2003, 3( 4 ): 443-458.
  • 6CHOWDHURY S, ERICKSON SW, MACLEOD SL, et al. Maternal genome-wide DNA methylation patterns and congenital heart defects [J].PLoSOne, 2011,6(1): e16506.
  • 7THIRLWELL C, EYMARD M, FEBER A, et al. Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChip [ J ]. Methods, 2010, 52( 3 ): 248-254.
  • 8BRUNNER A L, JOHNSON D S, KIM S W, et al. Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver[ J ]. Genome Res, 2009, 19 ( 6): 1044-1056.
  • 9HERMAN J G, BAYLIN S B. Gene silencing in cancer in association with promoter hypermethylation[ J ], N Engl J Med, 2003, 349( 21 ): 2042-2054.
  • 10BOLTZE C, ZACK S, QUEDNOW C, et aL Hypermethylation of the CDKN2/pl6INK4A promotor in thyroid carcinogenesis[ J ]. Pathol Res Pract, 2003, 199( 6 ): 399-404.

共引文献4

同被引文献3

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部